These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 751718)

  • 1. Melphalan and methotrexate in advanced breast cancer.
    Priestman TJ; Salaman PF
    Cancer Treat Rep; 1978 Dec; 62(12):2111-2. PubMed ID: 751718
    [No Abstract]   [Full Text] [Related]  

  • 2. Combination chemotherapy with CCNU, melphalan, methotrexate, and prednisone (CAMP) in 35 patients with advanced breast cancer.
    Hansen M; Palshof T; Osterlind K; Hansen HH; Mouridsen H
    Cancer Treat Rep; 1977 Nov; 61(8):1603-5. PubMed ID: 922762
    [No Abstract]   [Full Text] [Related]  

  • 3. CCNU, melphalan, methotrexate, and prednisone (CAMP) versus cyclophosphamide, methotrexate, and 5-fluorouracil (CMF) in the treatment of advanced breast cancer in postmenopausal women.
    Salimtschik M; Snel S; Havsteen H; Dombernowsky P; Mouridsen HT
    Cancer Treat Rep; 1980; 64(4-5):635-7. PubMed ID: 7000346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized phase II comparison of methotrexate with or without L-asparaginase in non-small cell cancer of the lung.
    Rudnick SA; Neijstrom E; Capizzi RL; Delaney D; Kirsch M
    Cancer Treat Rep; 1982 Mar; 66(3):541-4. PubMed ID: 7060040
    [No Abstract]   [Full Text] [Related]  

  • 5. [Use of "split" courses of combination chemotherapy in breast cancer].
    Dymarskiĭ LIu; Aleksandrova GI; Sanchakova AV
    Vopr Onkol; 1981; 27(7):82-5. PubMed ID: 7269435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral adjuvant therapy in breast carcinoma--a multicentre trial.
    Leiberman DP; Berstock DA; Houghton J; Kearney G
    Cancer Treat Rev; 1979 Jun; 6 Suppl():91-6. PubMed ID: 387233
    [No Abstract]   [Full Text] [Related]  

  • 7. Effectiveness of intermediate-dose methotrexate and high-dose 5-fluorouracil as sequential combination chemotherapy in refractory breast cancer and as primary therapy in metastatic adenocarcinoma of the colon.
    Tisman G; Wu SJ
    Cancer Treat Rep; 1980; 64(8-9):829-35. PubMed ID: 7448820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preliminary report of a clinical trial of the treatment of patients with advanced stage III and IV ovarian cancer with melphalan, 5-fluorouracil, and methotrexate in combination and sequentially: a study of the Clinical Trials Group of the National Cancer Institute of Canada.
    Klaassen DJ; Boyes DA; Gerulath A; Levitt M; Miller AB; Pearson JG
    Cancer Treat Rep; 1979 Feb; 63(2):289-95. PubMed ID: 376135
    [No Abstract]   [Full Text] [Related]  

  • 9. Combination versus sequential five-drug chemotherapy in metastatic carcinoma of the breast.
    Smalley RV; Murphy S; Huguley CM; Bartolucci AA
    Cancer Res; 1976 Nov; 36(11 Pt 1):3911-6. PubMed ID: 975039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disseminated breast carcinoma. Treatment with combination chemotherapy.
    Spigel SC; Coltman CA; Costanzi JJ
    Arch Intern Med; 1973 Oct; 132(4):575-7. PubMed ID: 4742410
    [No Abstract]   [Full Text] [Related]  

  • 11. Cyclical combination chemotherapy in advanced breast cancer.
    Edelstyn GA; Marcrae KD
    Ann R Coll Surg Engl; 1974 Jun; 54(6):275-6. PubMed ID: 4833779
    [No Abstract]   [Full Text] [Related]  

  • 12. Recent progress in breast cancer management. Combined modality (adjuvant) therapy.
    Cowan K; Lippman M
    Arch Intern Med; 1981 Jul; 141(8):1055-9. PubMed ID: 7018440
    [No Abstract]   [Full Text] [Related]  

  • 13. Mitomycin C, melphalan and methotrexate combination chemotherapy for palliation of disseminated breast cancer.
    Perez DJ; Powles TJ; Gazet JC; Ford HT; Coombes RC
    Cancer Chemother Pharmacol; 1984; 13(1):36-8. PubMed ID: 6203662
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase II study of mitomycin C and vinblastine in women with advanced breast cancer refractory to standard cytotoxic therapy.
    Denefrio JM; East DR; Troner MB; Vogel CL
    Cancer Treat Rep; 1978 Dec; 62(12):2113-5. PubMed ID: 751719
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of advanced carcinoma of the cervix with adriamycin and methotrexate combined.
    Guthrie D; Way S
    Obstet Gynecol; 1974 Oct; 44(4):586-9. PubMed ID: 4547341
    [No Abstract]   [Full Text] [Related]  

  • 16. Advances in the multimodal primary management of cancer.
    DeVita VT; Henney JE; Weiss RB
    Adv Intern Med; 1980; 26():115-29. PubMed ID: 7013437
    [No Abstract]   [Full Text] [Related]  

  • 17. [Combination chemotherapy with mitomycin C, methotrexate, and vincristine (MMV) for metastatic breast cancer refractory to adriamycin].
    Nomura Y; Kanda K; Tashiro H; Hamada Y; Saeki K
    Gan To Kagaku Ryoho; 1983 Mar; 10(3):824-8. PubMed ID: 6411002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An evaluation of five drug combination chemotherapy in the management of recurrent carcinoma of the breast.
    Lee JM; Abeloff MD; Lenhard RE; Baker RR
    Surg Gynecol Obstet; 1974 Jan; 138(1):77-80. PubMed ID: 4809006
    [No Abstract]   [Full Text] [Related]  

  • 19. Adriamycin versus adriamycin plus melphalan in advanced ovarian carcinoma.
    De Palo GM; De Lena M; Bonadonna G
    Cancer Treat Rep; 1977; 61(3):355-7. PubMed ID: 326402
    [No Abstract]   [Full Text] [Related]  

  • 20. [Cytostatic treatment of metastasizing breast cancer. A prospective controlled comparison between single drug and multiple drug chemotherapy].
    Mouridsen HT; Palshof T; Brahm M; Rahbek I
    Ugeskr Laeger; 1977 Oct; 139(44):2632-5. PubMed ID: 929742
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.